TipRanks
Entera Bio Ltd (ENTX)
NASDAQ:ENTX
US Market
ENTX
Entera Bio
RESEARCH TOOLSreports
Want to see ENTX full AI Analyst Report?

Entera Bio (ENTX) Stock News & Sentiment

486 Followers
Former Gilead and Amgen Commercial Leader Laura Hamill Just Joined Entera (NASDAQ: ENTX)
Premium
TipRanks Newswire
Former Gilead and Amgen Commercial Leader Laura Hamill Just Joined Entera (NASDAQ: ENTX)
4d ago
LLY
AMGN
Entera Bio Strengthens Board with Veteran Biopharma Leader
Premium
Company Announcements
Entera Bio Strengthens Board with Veteran Biopharma Leader
5d ago
8K
ENTX
Entera Bio Receives New Overweight Rating From Cantor Fitzgerald (NASDAQ: ENTX)
Premium
TipRanks Newswire
Entera Bio Receives New Overweight Rating From Cantor Fitzgerald (NASDAQ: ENTX)
18d ago
LLY
ENTX
Entera Receives $9 Price Target and New ‘Outperform’ Rating From Leerink Partners (NASDAQ: ENTX)
Premium
TipRanks Newswire
Entera Receives $9 Price Target and New ‘Outperform’ Rating From Leerink Partners (NASDAQ: ENTX)
23d ago
LLY
ENTX
Entera is on the Cusp of the Trial That Could Unlock America’s Osteoporosis Drug Market (NASDAQ: ENTX)
Premium
TipRanks Newswire
Entera is on the Cusp of the Trial That Could Unlock America’s Osteoporosis Drug Market (NASDAQ: ENTX)
1M ago
LLY
NVO
Entera Bio appoints new chief medical officer
Premium
Company Announcements
Entera Bio appoints new chief medical officer
2M ago
8K
ENTX
Entera Bio Strengthens Finances to Advance Oral Peptide Pipeline
Premium
Company Announcements
Entera Bio Strengthens Finances to Advance Oral Peptide Pipeline
2M ago
8K
ENTX
More ENTX News >

ENTX News on the Web

Guggenheim starts Entera with Buy on N-tab platform potential
TipRanks News
Neutral
Entera Bio initiated with an Outperform at Leerink
TipRanks News
Bullish
Entera Bio files to sell 134.8M ordinary shares for holders
TipRanks News
Bullish
Top Biotech Gainers: GOSS To File Seralutinib NDA In Sep, OMER Gains On AZN's Loss, FBRX Acquired
rttnews
Bullish
Top Biotech Gainers: CDNA Soars On Medicare Policy, ATAI Acquired, ABT Lifts Outlook, APLM On Watch
rttnews
Bullish
America's Osteoporosis Crisis and the Oral Peptide Player You Should Watch (NASDAQ: ENTX)
GuruFocus News
Bullish
Entera Bio: Buy Rating Reiterated on De-Risked Oral PTH Platform and FDA-Supported Phase 3 Design; $9 Price Target Maintained
TipRanks News
Bullish
FDA Feedback Clears Path for Entera Bio’s Pioneering Oral Osteoporosis Treatment—Phase 3 for EB613 Set to Begin Late 2026
Market Chameleon
Bullish

News Score - Last 7 Days

Neutral
ENTX
Sector Average
Media Buzz
This Week2 articles
Weekly Average2.75 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ENTX’s Media Buzz Sentiment?
2 articles about ENTX were published this week. In an average week, 2.75 articles are published.
    What is ENTX’s weekly average amount of articles?
    In an average week, 2.75 articles about ENTX are published.
      What is ENTX’s News Sentiment?
      100% of articles about ENTX were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        AMGNAmgen
        GKOSGlaukos
        OVIDOvid Therapeutics
        ABTAbbott Laboratories
        IQVIQVIA Holdings
        Showing the stocks with the most bullish news sentiment over the past week